Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Medexus Pharmaceuticals (TSE:MDP)
:MDP
Holding TSE:MDP?
Track your performance easily
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Sep 25, 2024 | Kenneth D'entremont Chief Executive Officer | xxxxxxxxxxxxx | C$7500 |
| Aug 28, 2024 | Brendon Buschman Senior Officer | xxxxxxxxxxxxx | C$12222 |
| Jul 03, 2024 | Brendon Buschman Senior Officer | xxxxxxxxxxxxx | C$26220 |
| Jun 29, 2024 | Kenneth D'entremont Chief Executive Officer | xxxxxxxxxxxxx | C$10750 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Medexus Pharmaceuticals (TSE:MDP)?
Currently, no data Available
What percentage of Medexus Pharmaceuticals (TSE:MDP) stock is held by institutional investors?
Currently, no data Available
What percentage of Medexus Pharmaceuticals (TSE:MDP) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Medexus Pharmaceuticals (TSE:MDP)?
Currently, no data Available
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.